Skip to main content

Table 1 Baseline characteristics of patients and the maximal standardized uptake values of every primary tumor

From: Comparison of primary target volumes delineated on four-dimensional CT and 18 F-FDG PET/CT of non-small-cell lung cancer

Patients (n)

Sex

Age (y)

Tumor location

Histology

Tumor stage

SUVmax

Tumor size* (mm)

Tumor volume+(cm3)

1

M

66

Upper lobe

Adenocarcinoma

T2N2

25.51

36

17.49

2

F

68

Lower lobe

Adenosquamous carcinoma

T2N2

11

46

139.72

3

M

70

Upper lobe

Adenocarcinoma

T2N2

7.71

18

4.81

4

M

79

Upper lobe

Adenocarcinoma

T1N2

8.8

33

26.40

5

F

49

Lower lobe

Squamous cell carcinoma

T2N2

8.85

38

38.59

6

M

66

Upper lobe

Squamous cell carcinoma

T2N2

14.41

33

16.28

7

M

75

Upper lobe

Squamous cell carcinoma

T2N2

12.39

32

14.37

8

F

65

Upper lobe

Adenocarcinoma

T2N2

13.41

25

8.12

9

M

76

Lower lobe

Squamous cell carcinoma

T3N2

15.13

52

115.42

10

M

84

Lower lobe

Adenocarcinoma

T2N2

24.81

40

27.53

11

M

68

Upper lobe

Squamous cell carcinoma

T2N2

9.83

40

45.97

12

M

65

Upper lobe

Adenocarcinoma

T2N3

14.38

42

39.43

13

F

67

Upper lobe

Adenocarcinoma

T1N3

6.99

15

5.96

14

M

65

Upper lobe

Squamous cell carcinoma

T4N2

14.52

80

157.67

15

M

45

Upper lobe

Adenocarcinoma

T1N3

6.09

10

5.06

16

M

65

Lower lobe

Adenocarcinoma

T1N2

6.07

24

4.53

17

M

60

Upper lobe

Squamous cell carcinoma

T4N1

11.34

34

19.95

  1. SUVmax, maximal standardized uptake value; *Tumor sizes represent the major axis of the tumor; +Tumor volume is the average volume of the 10 phases of the gross target volume delineated on four-dimensional CT.